Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.31 |
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7535823 | 0.80 | TK1 (0.35) | TK1MAPK1HPGDSQORTYMP | |
| SCHEMBL6403634 | 0.75 | TK1 (0.35) | TK1MAPK1HPGDSQORTYMP | |
| SCHEMBL16260046 | 0.75 | TYMP (0.46) | TK1MAPK1HPGDTYMP | |
| SCHEMBL7535814 | 0.73 | TK1 (0.35) | TK1MAPK1HPGDSQORTYMP | |
| SCHEMBL16653120 | 0.72 | TK1 (0.43) | TK1MAPK1HPGDTYMP | |
| SCHEMBL8045900 | 0.70 | TK1 (0.46) | TK1MAPK1HPGDTYMP | |
| SCHEMBL12924143 | 0.68 | CA14 (0.47) | — | |
| SCHEMBL16263426 | 0.68 | DUT (0.43) | TK1MAPK1HPGDTYMP | |
| SCHEMBL11521511 | 0.68 | CA14 (0.39) | — | |
| SCHEMBL14542978 | 0.68 | MAPK1 (0.40) | TK1MAPK1HPGDTYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0734391-B1 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS INC (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1201676-A2 | PNA-DNA-PNA chimeric macromolecules | ISIS PHARMACEUTICALS, INC. (US) | 2002-05-02 | — | — | EP | disclosed |
| US-6277603-B1 | PEPTIDE NUCLEIC ACID (PNA); THE DNA PORTION IS COMPOSED OF SUBUNITS OF AT LEAST ONE 2'-DEOXYNUCLEOTIDES; INCREASED NUCLEASE RESISTANCE; ACTIVATE RNASE H ENZYME, USE FOR IN VITRO MODIFICATION OF RNA | ISIS PHARMACEUTICALS, INC. | 2001-08-21 | — | — | US | disclosed |
| EP-0734391-A4 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS INC (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5700922-A | INCREASED NUCLEASE RESISTANCE, INCREASED BINDING AFFINITY TO COMPLEMENTARY STRANDS; MEDICAL DIAGNOSIS, THERAPY | ISIS PHARMACEUTICALS, INC. (US) | 1997-12-23 | — | — | US | disclosed |
| US-5629152-A | SYNTHETIC POLYPEPTIDES WITH DOUBLE HELICAL STRUCTURE, BINDING TO DNA AND RNA STRANDS, CONTAIN AZETIDINE RING | ISIS PHARMACEUTICALS, INC. (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0734391-A1 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-02 | — | — | EP | disclosed |
| WO-1995014706-A1 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | disclosed |